Detail
Article
Online article
FT
Medvik - BMC
  • Something wrong with this record ?

Multilayered Polyurethane/Poly(vinyl alcohol) Nanofibrous Mats for Local Topotecan Delivery as a Potential Retinoblastoma Treatment

R. Hobzova, J. Sirc, K. Shrestha, B. Mudrova, Z. Bosakova, M. Slouf, M. Munzarova, J. Hrabeta, T. Feglarova, AI. Cocarta

. 2023 ; 15 (5) : . [pub] 20230503

Status not-indexed Language English Country Switzerland

Document type Journal Article

Local chemotherapy using polymer drug delivery systems has the potential to treat some cancers, including intraocular retinoblastoma, which is difficult to treat with systemically delivered drugs. Well-designed carriers can provide the required drug concentration at the target site over a prolonged time, reduce the overall drug dose needed, and suppress severe side effects. Herein, nanofibrous carriers of the anticancer agent topotecan (TPT) with a multilayered structure composed of a TPT-loaded inner layer of poly(vinyl alcohol) (PVA) and outer covering layers of polyurethane (PUR) are proposed. Scanning electron microscopy showed homogeneous incorporation of TPT into the PVA nanofibers. HPLC-FLD proved the good loading efficiency of TPT (≥85%) with a content of the pharmacologically active lactone TPT of more than 97%. In vitro release experiments demonstrated that the PUR cover layers effectively reduced the initial burst release of hydrophilic TPT. In a 3-round experiment with human retinoblastoma cells (Y-79), TPT showed prolonged release from the sandwich-structured nanofibers compared with that from a PVA monolayer, with significantly enhanced cytotoxic effects as a result of an increase in the PUR layer thickness. The presented PUR-PVA/TPT-PUR nanofibers appear to be promising carriers of active TPT lactone that could be useful for local cancer therapy.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc23009839
003      
CZ-PrNML
005      
20230721095435.0
007      
ta
008      
230707s2023 sz f 000 0|eng||
009      
AR
024    7_
$a 10.3390/pharmaceutics15051398 $2 doi
035    __
$a (PubMed)37242640
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a sz
100    1_
$a Hobzova, Radka $u Institute of Macromolecular Chemistry, Czech Academy of Sciences, 162 06 Prague, Czech Republic $1 https://orcid.org/0000000268688046
245    10
$a Multilayered Polyurethane/Poly(vinyl alcohol) Nanofibrous Mats for Local Topotecan Delivery as a Potential Retinoblastoma Treatment / $c R. Hobzova, J. Sirc, K. Shrestha, B. Mudrova, Z. Bosakova, M. Slouf, M. Munzarova, J. Hrabeta, T. Feglarova, AI. Cocarta
520    9_
$a Local chemotherapy using polymer drug delivery systems has the potential to treat some cancers, including intraocular retinoblastoma, which is difficult to treat with systemically delivered drugs. Well-designed carriers can provide the required drug concentration at the target site over a prolonged time, reduce the overall drug dose needed, and suppress severe side effects. Herein, nanofibrous carriers of the anticancer agent topotecan (TPT) with a multilayered structure composed of a TPT-loaded inner layer of poly(vinyl alcohol) (PVA) and outer covering layers of polyurethane (PUR) are proposed. Scanning electron microscopy showed homogeneous incorporation of TPT into the PVA nanofibers. HPLC-FLD proved the good loading efficiency of TPT (≥85%) with a content of the pharmacologically active lactone TPT of more than 97%. In vitro release experiments demonstrated that the PUR cover layers effectively reduced the initial burst release of hydrophilic TPT. In a 3-round experiment with human retinoblastoma cells (Y-79), TPT showed prolonged release from the sandwich-structured nanofibers compared with that from a PVA monolayer, with significantly enhanced cytotoxic effects as a result of an increase in the PUR layer thickness. The presented PUR-PVA/TPT-PUR nanofibers appear to be promising carriers of active TPT lactone that could be useful for local cancer therapy.
590    __
$a NEINDEXOVÁNO
655    _2
$a časopisecké články $7 D016428
700    1_
$a Sirc, Jakub $u Institute of Macromolecular Chemistry, Czech Academy of Sciences, 162 06 Prague, Czech Republic
700    1_
$a Shrestha, Kusum $u Institute of Macromolecular Chemistry, Czech Academy of Sciences, 162 06 Prague, Czech Republic
700    1_
$a Mudrova, Barbora $u Department of Analytical Chemistry, Faculty of Science, Charles University, 128 43 Prague, Czech Republic
700    1_
$a Bosakova, Zuzana $u Department of Analytical Chemistry, Faculty of Science, Charles University, 128 43 Prague, Czech Republic $1 https://orcid.org/0000000284835739 $7 jo2005273839
700    1_
$a Slouf, Miroslav $u Institute of Macromolecular Chemistry, Czech Academy of Sciences, 162 06 Prague, Czech Republic $1 https://orcid.org/000000031528802X $7 xx0107048
700    1_
$a Munzarova, Marcela $u Nanomedical Co., Ltd., 463 12 Liberec, Czech Republic
700    1_
$a Hrabeta, Jan $u Department of Pediatric Hematology and Oncology, 2nd Faculty of Medicine, Charles University and Motol University Hospital, 150 06 Prague, Czech Republic
700    1_
$a Feglarova, Tereza $u Department of Pediatric Hematology and Oncology, 2nd Faculty of Medicine, Charles University and Motol University Hospital, 150 06 Prague, Czech Republic
700    1_
$a Cocarta, Ana-Irina $u Institute of Macromolecular Chemistry, Czech Academy of Sciences, 162 06 Prague, Czech Republic
773    0_
$w MED00186380 $t Pharmaceutics $x 1999-4923 $g Roč. 15, č. 5 (2023)
856    41
$u https://pubmed.ncbi.nlm.nih.gov/37242640 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y p $z 0
990    __
$a 20230707 $b ABA008
991    __
$a 20230721095428 $b ABA008
999    __
$a ok $b bmc $g 1958525 $s 1196103
BAS    __
$a 3
BAS    __
$a PreBMC-PubMed-not-MEDLINE
BMC    __
$a 2023 $b 15 $c 5 $e 20230503 $i 1999-4923 $m Pharmaceutics $n Pharmaceutics $x MED00186380
LZP    __
$a Pubmed-20230707

Find record

Citation metrics

Loading data ...

Archiving options

Loading data ...